Afyren: TP ICAP Midcap Initiates Coverage with a Buy Rating and a Target of €4.8
TP ICAP Midcap begins analytical coverage of the greentech company Afyren with a buy recommendation and a price target of €4.8 per share. This initiation strengthens the existing consensus from two other analysts, who maintain positive positions on the stock.
New Analytical Coverage with a Target Above Consensus
TP ICAP Midcap, specializing in tracking small and medium-sized capitalizations, initiated coverage of Afyren stock on Thursday with a buy recommendation and a price target of €4.8 per share. The initiation report, titled 'Time for Industrial Execution', focuses on the company's phase of industrial execution. This new coverage accompanies existing analyses from BNPP Portzamparc and ODDO BHF, both of whom also maintain a buy recommendation. The consensus from the two existing analysts (BNPP Portzamparc and ODDO BHF) sets a price target of €4.5, slightly below that of TP ICAP Midcap.
Fundamentals of Greentech Under Investor Scrutiny
Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
✓ Before 9 AM every morning✓ Euronext data✓ AI-powered analysis
You're in — subscription confirmed!
Your first edition is on its way. Check your spam folder and add us to your contacts.
An error occurred.
Indicative data. No investment advice. Unsubscribe at any time.
Gratuit · chaque matin
Ne ratez plus rien sur vos actions
La tendance derrière les cours. L'essentiel des valeurs Euronext en quelques minutes.
📈les valeurs en mouvement, sur la durée
🎯les objectifs d'analystes qui évoluent
📰les actualités qui font bouger les cours
tendance · 6 séances
✓ C'est fait, vous êtes inscrit !
Votre première édition arrive bientôt. Pensez à vérifier vos spams.
Une erreur est survenue.
CAC 40 · SBF 120 · données indicatives · aucun conseil en investissement · désinscription à tout moment.
Afyren develops proprietary fermentation technology that transforms agricultural biomass into biologically-based carboxylic acids with a low carbon footprint. The Neoxy production plant, located in the Grand-Est region, primarily serves the European market and caters to sectors such as nutrition, flavors and fragrances, life sciences, and materials. The company employs 140 people by the end of 2025 at its sites in Lyon, Clermont-Ferrand, and Carling-Saint-Avold, and allocates 20% of its annual budget to research and development. Analysts are now closely monitoring the operational progress and execution of international expansion plans, particularly in Asia and the Americas.
AFYREN est en train de produire et d'expédier à un rythme croissant.
Le momentum commercial est très positif, soutenu par les commandes clients.
Risks mentioned
Préoccupations croissantes sur la disponibilité et le prix des ressources fossiles.
Opportunities identified
Accélération de la production grâce aux améliorations des processus.
Renforcement du positionnement commercial unique d'AFYREN par des certifications.
The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.
Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.
